Clinical Trials

Clinical trials are studies that are designed to test whether treatments are safe and effective at improving outcomes for patients.

Clinical trials are divided into different phases depending on the stage of drug development. The earlier phases (phase I and II) look at whether a drug is safe (e.g. to understand the side effects it causes) and whether it shows some signs of efficacy (e.g. a higher response rate than expected in the intended group of patients). Later phase III trials aim to test whether a new promising treatment is better than the best currently available treatments.

In this section, you will learn about the importance of clinical trials, where you can obtain more information on the on-going AML trials and what you can expect if you would like to be part of one. Many physicians will recommend at least discussing the trial opportunities available since it is a chance to receive the best standard of care in a top institute, where you will be very closely monitored.

If you have any questions or concerns, don’t hesitate to discuss these with your healthcare team, as well as contacting patient support groups. 

 

Videos

Finding the Right Match: Advice for Patients Who Qualify for Multiple Clinical Trials

Which clinical trial is the best choice for you? Watch now to hear Dr. Mike Thompson and patient advocate Jim Omel discuss factors to consider when weighing your options and share tips for patients trying to prioritize different trials.

Published:

Step One in Trial Participation: How Can Patients Learn About New Trials?

Myeloma survivor Reina Weiner and Lazarex chairman Dana Dornsife discuss ways patients can learn about new clinical trial opportunities and share resources to help alleviate the financial burden.

Published:

Transparency in Clinical Trials: Data, Safety and Monitoring of Cancer Patients

Many patients wonder; how safe are clinical trials? How transparent is the data from clinical research? Tune in to hear Dr. Mike Thompson and Jim Omel discuss clinical trial care and how the efficacy of new cancer treatments is determined.

Published:

Evaluating Inclusion and Exclusion Criteria in Clinical Trials

Eligibility criteria determines who can and cannot participate in a clinical trial. Do today’s studies reflect the actual patient population? Why is inclusion so narrow in some cases? Watch now to hear from Dr. Mike Thompson and Jim Omel.

Published:

Actionable Advice and Resources for Knocking Down Obstacles to Trial Participation

More often than not, only a small fraction of patients enroll in a trial due to barriers posed by financial logistics, distrust and travel, to name a few. How do we remove obstacles, clearing the way for patients to have more access to clinical trials? Watch now to find out.

Published:

Precision Medicine: Can Biomarkers Help Patients Find a Good Fit for Clinical Trials?

A panel of experts discuss how precision medicine may influence trial eligibility, cost of treatment, pace of drug development and more. Can biomarkers make the clinical trial process more efficient? Watch now to find out.

Published:

Community Level Care: Are Clinical Trials Available in Small Cities?

Are innovative treatments and testing offered closer to home? Expert Dr. Mike Thompson discusses local clinical trial options for cancer patients.

Published:

Randomization in Clinical Trials: An Expert Explains Patient Equality

Patient advocate Jim Omel tackles the hot-button issue of randomization in clinical trials. What determines patient equality? How are treatments allocated amongst patients? Watch now to learn more.

Published:

How Can Clinical Trials Be Improved to Enhance the Patient Experience?

Patient advocate Jim Omel and leading expert Dr. Mike Thompson break down the design and purpose of clinical trials and give their perspective on how it could be more patient-friendly.

Published:

Showing 9 of 11 programs
Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on March 8, 2017